Leptin Receptor Antagonists' Action on HDAC Expression Eliminating the Negative Effects of Leptin in Ovarian Cancer

Conclusion: SHLA and Lan2 eliminate the negative effects of leptin on HDAC expression in a cell-type-dependent manner. This is the first report testing leptin receptor blockers as HDAC inhibitors in ovarian cancer cells.

Source: Cancer Genomics and Proteomics - July 5, 2018 Category: Cancer & Oncology Authors: FIEDOR, E., ZAJDA, K., GREGORASZCZUK, E. L. Tags: Article Source Type: research